Ken Griffin Genocea Biosciences, Inc. Transaction History

Citadel Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $18,431 - $2.54 Million	-1,843,112 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.96 - $1.35 $45,712 - $64,282	47,617 Added 2.65%	1,843,112 $2.3 Million
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.99 $55,414 - $116,078	-58,331 Reduced 3.15%	1,795,495 $2.08 Million
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.33 $32,033 - $42,895	-18,410 Reduced 0.98%	1,853,826 $3.56 Million
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.82 $85,387 - $116,889	41,450 Added 2.26%	1,872,236 $4.38 Million
Q1 2021 May 17, 2021	BUY	$2.35 - $4.01 $51,826 - $88,436	22,054 Added 1.22%	1,830,786 $4.96 Million
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.67 $20,492 - $28,646	10,729 Added 0.6%	1,808,732 $4.38 Million
Q3 2020 Nov 16, 2020	BUY	$1.81 - $5.53 $3.18 Million - $9.72 Million	1,758,244 Added 4422.25%	1,798,003 $4.12 Million
Q2 2020 Aug 14, 2020	BUY	$1.66 - $3.06 $31,284 - $57,668	18,846 Added 90.12%	39,759 $92,000
Q1 2020 May 15, 2020	SELL	$1.26 - $2.73 $37,096 - $80,376	-29,442 Reduced 58.47%	20,913 $36,000
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $73,558 - $101,187	35,882 Added 247.92%	50,355 $104,000
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $8,169 - $11,465	-2,817 Reduced 16.29%	14,473 $41,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $59,996 - $116,015	17,290 New	17,290 $68,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.